Washington [US], June 14 (ANI): A new global study published in BMC Psychiatry reports that 34 per cent of people with premenstrual dysphoric disorder have attempted suicide.
Salt Lake City (Utah) [US], May 3 (ANI): Researchers from SWOG Cancer Research Network have significantly extended median survival for patients with hormone-sensitive metastatic prostate cancer. This result comes from a large randomized clinical trial aimed at testing a new treatment for the
Washington [US], October 9 (ANI): Researchers at the Medical College of Wisconsin Cancer Center and an international team of collaborators recently unlocked drug testing of hormone-sensitive human breast cancer through a mouse model.
Washington [US], October 4 (ANI): During a recent study, researchers at the Medical College of Wisconsin Cancer Center and an international team of collaborators generated mice with an improved hormone profile that supports growth and metastatic spread of implanted human breast tumours.
Washington D.C. [USA], June 2 (ANI): A new study reveals that Enzalutamide, an oral androgen receptor inhibitor can yield better outcomes and increase survival for men with metastatic hormone-sensitive prostate cancer (mHSPC).